Drug Trial Radar · NCT04759131
Safety, Efficacy and PK of BIVV001 in Pediatric Patients With Hemophilia A
Last checked: Nov 19, 2026Latest source record: Sep 11, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
74
Actual
Start
Feb 19, 2021
Primary completion
Jan 18, 2023
Study completion Jan 18, 2023
Sponsor
- Lead sponsor
- Bioverativ, a Sanofi companySanofi (SNY)
- Sponsor type
- Industry
- First posted
- Feb 18, 2021
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- Male only, up to 11 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Primary Objective: \- To evaluate the safety of BIVV001 in previously treated pediatric participants with hemophilia A. Secondary Objectives: * To evaluate the efficacy of BIVV001 as a prophylaxis treatment. * To evaluate the efficacy of BIVV001 in the treatment of bleeding episodes. * To evaluate BIVV001 consumption for prevention and treatment of bleeding episodes. * To evaluate the effect of BIVV001 prophylaxis on joint health outcomes. * To evaluate the effect of BIVV001 prophylaxis on Quality of Life (QoL) outcomes. * To evaluate the efficacy of BIVV001 for perioperative management. * To evaluate the safety and tolerability of BIVV001 treatment. * To assess the pharmacokinetics (PK) of BIVV001.
Conditions
- Hemophilia A
Interventions
efanesoctocog alfa (BIVV001)Drug
Pharmaceutical form: solution for injection Route of administration: IV
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With Neutralising Antibodies (Development of Inhibitors) Directed Against Factor VIIITime frame: Baseline up to Week 52
Locations
40 sites in 15 countries. Site status is shown where the registry gives one.
Children's Hospital Los Angeles-Site Number:8400006
Los Angeles, California
University of Florida-Site Number:8400009
Gainesville, Florida
Children's Healthcare of Atlanta-Site Number:8400019
Atlanta, Georgia
Rush University Medical Center-Site Number:8400001
Chicago, Illinois
University of Iowa Hospitals and Clinics-Site Number:8400002
Iowa City, Iowa
NY Presbyterian - Weill Cornell Medical Center-Site Number:8400020
New York, New York
East Carolina University/Brody Medical Sciences Building-Site Number:8400015
Greenville, North Carolina
Cincinnati Children's Hospital Medical Center-Site Number:8400008
Cincinnati, Ohio
Childrens Hospital Of Columbus-Site Number:8400012
Columbus, Ohio
Children's Hospital Of Wisconsin-Site Number:8400005
Milwaukee, Wisconsin
Investigational Site Number :0360001
Westmead, New South Wales, Australia
Investigational Site Number :0360002
South Brisbane, Queensland, Australia
Investigational Site Number :1240004
Hamilton, Ontario, Canada
Investigational Site Number :1240003
London, Ontario, Canada
Investigational Site Number :1240002
Ottawa, Ontario, Canada
Investigational Site Number :1240001
Toronto, Ontario, Canada
Investigational Site Number :2500004
Bron, France
Investigational Site Number :2500001
Le Kremlin-Bicêtre, France
Investigational Site Number :2500003
Lille, France
Investigational Site Number :2760001
Frankfurt am Main, Germany
Investigational Site Number :2760002
München, Germany
Investigational Site Number :3480005
Pécs, Hungary
Investigational Site Number :3720001
Dublin, Ireland
Investigational Site Number :3800001
Milan, Italy
Investigational Site Number :3800002
Naples, Italy
Investigational Site Number :5280002
Amsterdam, Netherlands
Investigational Site Number :5280001
Utrecht, Netherlands
Investigational Site Number :7240002
Esplugues de Llobregat, Catalunya [Cataluña], Spain
Investigational Site Number :7240001
Madrid, Madrid, Comunidad de, Spain
Investigational Site Number :7520001
Malmö, Sweden
Investigational Site Number :7560001
Zurich, Switzerland
Investigational Site Number :1580001
Taichung, Taiwan
Investigational Site Number :1580003
Taichung, Taiwan
Investigational Site Number :1580002
Taipei, Taiwan
Investigational Site Number :1580004
Taipei, Taiwan
Investigational Site Number :7920004
Antalya, Turkey (Türkiye)
Investigational Site Number :7920001
Istanbul, Turkey (Türkiye)
Investigational Site Number :7920003
Izmir, Turkey (Türkiye)
Investigational Site Number :8260003
Birmingham, United Kingdom
Investigational Site Number :8260001
London, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.